TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three March 12, 1976
TCL Archive Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years March 6, 1998
TCL Archive Professional Societies: ASCO Foundation Formed to Support Fellowship Awards June 11, 1999
TCL Archive Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds November 25, 2005
